Learn / DNLI
NASDAQ: DNLI
Denali Therapeutics (DNLI) stock, explained like you're 5
Denali Therapeutics trades on the Nasdaq under the ticker DNLI. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 3.1 billion dollars.
- Ticker
- DNLI
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 3.1 billion dollars
Is Denali Therapeutics a small, medium or large cap company?
No. Denali Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Denali Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DNLI stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Denali Therapeutics Inc. (DNLI) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Denali Therapeutics Inc. (DNLI) stock price, news, quote and history (Yahoo Finance UK)
- Denali Therapeutics (DNLI) Looks Undervalued On Paper, Where Does Fair Value Really Sit? (Simply Wall Street)
- Denali Therapeutics Inc. (DNLI) stock price, news, quote and history (Yahoo Finance Singapore)
- Denali Therapeutics Inc. (DNLI) latest stock news and headlines (Yahoo Finance UK)
Follow DNLI in your daily brief
Each trading day at 5 PM ET we post what happened to Denali Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DNLI
Questions about Denali Therapeutics stock
What does Denali Therapeutics do?
Denali Therapeutics trades on the Nasdaq under the ticker DNLI. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 3.1 billion dollars.
What is the ticker symbol for Denali Therapeutics?
Denali Therapeutics trades under the ticker DNLI on the Nasdaq.
What is Denali Therapeutics's market cap?
Denali Therapeutics is a mid cap stock with a market cap of about 3.1 billion dollars.
How does Denali Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DNLI stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DNLI stock every day?
Add DNLI to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.